The uncovering and characterization of a CCKoma syndrome in enteropancreatic neuroendocrine tumor patients

References

• Barakat MT, Meeran K, Bloom SR. Neuroendocrine tumours. Endocr Relat Cancer. 2004;11:1–18.
   PubMed Web of Science ®Google Scholar
• Modlin IM, Öberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9:61–72.
   PubMed Web of Science ®Google Scholar
• Klimstra DS, Modlin IM, Coppola D, et al. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas. 2010;39:707–712.
   PubMed Web of Science ®Google Scholar
• Lawrence B, Gustafsson BI, Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin N Am. 2011;40:1–18.
   PubMed Web of Science ®Google Scholar
• Ivy AC, Oldberg E. A hormone mechanism for gallbladder contraction and evacuation. Am J Physiol. 1928;86:599–613.
   Google Scholar
• Harper AA, Raper HS. Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine. J Physiol (Lond). 1943;102:115–125.
   Google Scholar
• Gibbs J, Young RC, Smith GP. Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature. 1973;245:323–325.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF. Clinical endocrinology and metabolism. Cholecystokinin. Best Pract Res Clin Endocrinol Metab. 2004;18:569–586.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Friis-Hansen L, Goetze JP, et al. The biology of cholecystokinin and gastrin peptides. Curr Top Med Chem. 2007;7:1154–1165.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, van Solinge WW. The tumor biology of gastrin and cholecystokinin. Adv Cancer Res. 1994;63:295–347.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Lindholm J, Andersen BN, et al. Pituitary tumors containing cholecystokinin. N Engl J Med. 1987;316:1244–1247.
   PubMed Web of Science ®Google Scholar
• Bardram L, Hilsted L, Rehfeld JF. Cholecystokinin, gastrin and their precursors in pheochromocytomas. Acta Endocrinol. 1989;120:479–484.
   PubMedGoogle Scholar
• Rehfeld JF, Johnsen AH, Ødum L, et al. Non-sulphated cholecystokinin in human medullary thyroid carcinomas. J Endocrinol. 1990;124:501–506.
   PubMed Web of Science ®Google Scholar
• Reubi JC, Koefoed P, Hansen TO, et al. Procholecystokinin as marker of human Ewing sarcomas. Clin Cancer Res. 2004;10:5523–5530.
   PubMed Web of Science ®Google Scholar
• Oikonomou E, Buchfelder M, Adams EF. Cholecystokinin (CCK) and CCK receptor expression by human gliomas: evidence for an autocrine/paracrine stimulatory loop. Neuropeptides. 2008;42:255–265.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF. How to measure cholecystokinin in tissue, plasma and cerebrospinal fluid. Regul Pept. 1998;78:31–39.
   PubMedGoogle Scholar
• Rehfeld JF. Accurate measurement of cholecystokinin in plasma. Clin Chem. 1998;44:991–1001.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Federspiel B, Bardram L. A neuroendocrine tumor syndrome from cholecystokinin secretion. N Engl J Med. 2013;368:1165–1166.
   PubMed Web of Science ®Google Scholar
• Paloheimo LI, Rehfeld JF. Quantitation of procholecystokinin and its products in plasma by processing-independent analysis. Clin Chim Acta. 1995;238:21–33.
   PubMed Web of Science ®Google Scholar
• Jensen TB, Hilsted L, Rehfeld JF. Library of sequence-specific radioimmunoassays for human chromogranin A. Clin Chem. 1999;45:549–560.
   PubMed Web of Science ®Google Scholar
• Stadil F, Rehfeld JF. Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay. Scand J Gastroenterol. 1973;8:101–112.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Stadil F. The effect of gastrin on basal- and glucose-stimulated insulin secretion in man. J Clin Invest. 1973;52:1415–1426.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Holst JJ, Kühl C. The effect of gastrin on basal and aminoacid-stimulated insulin and glucagon secretion in man. Eur J Clin Invest. 1978;8:5–9.
   PubMed Web of Science ®Google Scholar
• Schwartz TW, Holst JJ, Fahrenkrug J, et al. Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest. 1978;61:781–789.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF. Sequence-specific radioimmunoassays for cholecystokinin, gastrin and somatostatin. Biomed Res. 1980;(Suppl. 1):73–78.
   Web of Science ®Google Scholar
• Fahrenkrug J, Schaffalitzky de Muckadell OB. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. J Lab Clin Med. 1977;89:1379–1388.
   PubMed Web of Science ®Google Scholar
• Agersnap M, Rehfeld JF. Measurement of nonsulfated cholecystokinins. Scand J Clin Lab Invest. 2014;74:424–431.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF. The new biology of gastrointestinal hormones. Physiol Rev. 1998;78:1087–1108.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF. Beginnings: a reflection on the history of gastrointestinal endocrinology. Regul Pept. 2012;177:S1–S5.
   PubMed Web of Science ®Google Scholar
• Madsen OD, Larsson LI, Rehfeld JF, et al. Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J Cell Biol. 1986;103:2025–2034.
   PubMed Web of Science ®Google Scholar
• Madsen OD, Karlsen C, Nielsen E, et al. The dissociation of tumor-induced weight loss from hypoglycemia in a transplantable pluripotent rat islet tumor results in the segregation of stable alpha- and beta-cell tumor phenotypes. Endocrinology. 1993;133:2022–2030.
   PubMed Web of Science ®Google Scholar
• de Herder WW, Rehfeld JF, Kidd M, et al. A short history of neuroendocrine tumours and their peptide hormones. Best Pract Res Clin Endocrinol Metab. 2016;30:3–17.
   PubMed Web of Science ®Google Scholar
• Wolfe MM, Jain DK, Edgerton JR. Zollinger-Ellison syndrome associated with persistently normal fasting serum gastrin concentrations. Ann Intern Med. 1985;103:215–217.
   PubMed Web of Science ®Google Scholar
• Zimmer T, Stölzel U, Bäder M, et al. Brief report: a duodenal gastrinoma in a patient with diarrhea and normal serum gastrin concentrations. N Engl J Med. 1995;333:634–636.
   PubMed Web of Science ®Google Scholar
• Rehfeld JF, Gingras MH, Bardram L, et al. The Zollinger-Ellison syndrome and mismeasurement of gastrin. Gastroenterology. 2011;140:1444–1453.
   PubMed Web of Science ®Google Scholar
• Moschetta A, Stolk MFJ, Rehfeld JF, et al. Severe impairment of postprandial cholecystokinin release and gallbladder emptying and high risk of gallstone formation in acromegalic patients during Sandastatin LAR. Aliment Pharmacol Ther. 2001;15:181–185.
   PubMed Web of Science ®Google Scholar
• Rindi G, Arnold R, Bosman FT, et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban RH, et al. editors. WHO Classification of Tumours of the Digestive System. 4th ed. Lyon (France): Int Agency Res Cancer (IARC); 2010. pp. 13–14.
   Google Scholar
• Wolkowitz OM, Gertz B, Weingartner H, et al. Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist. Biol Psychiatry. 1990;28:169–173.
   PubMed Web of Science ®Google Scholar